At Sneed & Mitchell LLP , we are actively representing clients who suffered gastroparesis, intestinal blockage, and related conditions after taking GLP-1 medications
These medicines have become increasingly important in the management of type 2 diabetes and, more recently, obesity
These include effects such as headaches, higher heart rate, anxiety, increased gastrointestinal distress, dehydration, and slower weight loss rates
After 48 weeks, 36%-48% of subjects receiving 8 mg and 12 mg doses achieved 25% weight reduction, with no participants in the placebo group reaching this level
Women experiencing menopause, individuals with thyroid disorders, or those with insulin resistance may see different results compared to metabolically healthy individuals
add it slowly and pair it with adequate fluids